Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MEDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MEDP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Medpace Holdings Inc

MEDP
Current price
308.64 USD +2.02 USD (+0.66%)
Last closed 309.36 USD
ISIN US58506Q1094
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 8 699 795 456 USD
Yield for 12 month -24.37 %
1Y
3Y
5Y
10Y
15Y
MEDP
21.11.2021 - 28.11.2021

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

300.30 USD

P/E ratio

23.09

Dividend Yield

Financials MEDP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MEDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 109 054 000 USD

Last Year

+1 885 842 000 USD

Current Quarter

+558 570 000 USD

Last Quarter

+536 589 000 USD

Current Year

+656 305 000 USD

Last Year

+524 505 000 USD

Current Quarter

+178 350 000 USD

Last Quarter

+178 317 000 USD
EBITDA 485 512 992 USD
Operating Margin TTM 20.32 %
Price to Earnings 23.09
Return On Assets TTM 15.45 %
PEG Ratio 3.48
Return On Equity TTM 65.83 %
Wall Street Target Price 300.30 USD
Revenue TTM 2 156 580 096 USD
Book Value 19.94 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 9.30 %
Dividend Yield
Gross Profit TTM 1 468 161 024 USD
Earnings per share 13.11 USD
Diluted Eps TTM 13.11 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 14.70 %
Profit Margin 19.31 %

Stock Valuation MEDP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 23.09
Forward PE 24.63
Enterprise Value Revenue 3.89
Price Sales TTM 4.03
Enterprise Value EBITDA 17.27
Price Book MRQ 14.66

Technical indicators MEDP

For 52 weeks

250.05 USD 459.77 USD
50 Day MA 298.96 USD
Shares Short Prior Month 2 895 416
200 Day MA 327.98 USD
Short Ratio 9.29
Shares Short 3 154 685
Short Percent 13.81 %